Virtus Biotech ETF (BBP)

Assets	$131.05M
Expense Ratio	0.34%
PE Ratio	14.93
Forward PE	17.95
Shares Out	1.25M
Dividend	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	n/a
Open	n/a
Previous Close	100.71
Day's Range	n/a
52-Week Low	70.30
52-Week High	110.05
Beta	0.57
Holdings	68
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus Biotech ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSE Arca
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

28.12% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	5.80%
Iovance Biotherapeutics, Inc.	IOVA	4.76%
Omeros Corporation	OMER	2.89%
Verastem, Inc.	VSTM	2.43%
Precigen, Inc.	PGEN	2.25%
Halozyme Therapeutics, Inc.	HALO	2.11%
Kiniksa Pharmaceuticals International, plc	KNSA	2.02%
Xeris Biopharma Holdings, Inc.	XERS	2.01%
Novavax, Inc.	NVAX	1.93%
Rigel Pharmaceuticals, Inc.	RIGL	1.92%

Performance

BBP had a total return of 43.44% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.23%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Oct 15, 2026

Data Sources Report a data error